ASTRAZENECA PHARMACEUTICALS LP

DE
Filings
102
Firms Hired
1
Total Expenses
$72,746,713
Years Active
2007–2026

Filings

All 20262025202420232022202120202019201820172016201520142013201220112010200920082007
YearFirmPeriodExpensesDoc
2012 ASTRAZENECA PHARMACEUTICALS LP 3rd Quarter (July 1 - Sep 30)
AMENDED 		$900,000
2012 ASTRAZENECA PHARMACEUTICALS LP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		$340,000
2012 ASTRAZENECA PHARMACEUTICALS LP 2nd Quarter (Apr 1 - June 30)
AMENDED 		$370,000
2012 ASTRAZENECA PHARMACEUTICALS LP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$980,000
2012 ASTRAZENECA PHARMACEUTICALS LP 1st Quarter (Jan 1 - Mar 31)
AMENDED 		$1,110,000
2012 ASTRAZENECA PHARMACEUTICALS LP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$360,000
2012 ASTRAZENECA PHARMACEUTICALS LP 1st Quarter (Jan 1 - Mar 31)
AMENDED 		$1,190,000
2012 ASTRAZENECA PHARMACEUTICALS LP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$1,180,000
Firms Hired
FirmFilingsExpenses
ASTRAZENECA PHARMACEUTICALS LP 102 $72,746,713
Issue Areas
IssueActivities
Medicare/Medicaid 102
Health Issues 102
Copyright/Patent/Trademark 85
Pharmacy 82
Taxation/Internal Revenue Code 66
Trade (domestic/foreign) 58
Consumer Issues/Safety/Products 42
Budget/Appropriations 13
Labor Issues/Antitrust/Workplace 7
Government Issues 6
Foreign Relations 5
Tariff (miscellaneous tariff bills) 5
Environment/Superfund 4
Medical/Disease Research/Clinical Labs 3
Insurance 3

Bills Mentioned in Filings

HR 3590 HR 1483 HR 2182 H.R. 5376 HR 2190 H.R. 3026 H.R. 3839 H.R. 3 S. 1435 H.R. 19 H.R. 2245 HR 2245 S.296 H.R. 2883 H.R. 5260 H.R. 3590 S. 1734 H.R. 2884 H.R. 2873 HR 3590 H.R. 5539 H.R.5376 H.R. 1946 HR 1628 HR 3026